The global Recombinant Human Bone Morphogenetic Protein-2 Reagent market size is predicted to grow from US$ 99 million in 2025 to US$ 174 million in 2031; it is expected to grow at a CAGR of 9.9% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
BMP-2 (bone morphogenetic protein-2) is one of the most widely studied BMPs with the strongest osteogenic activity. BMP-2 has the ability to induce undifferentiated mesenchymal stem cells to differentiate and proliferate into chondrocytes and osteoblasts, promote osteoblast differentiation and maturation, participate in the growth and development of bones and cartilage and their reconstruction, and thus accelerate the repair of bone defects.
United States market for Recombinant Human Bone Morphogenetic Protein-2 Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Recombinant Human Bone Morphogenetic Protein-2 Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Recombinant Human Bone Morphogenetic Protein-2 Reagent is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Recombinant Human Bone Morphogenetic Protein-2 Reagent players cover Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淩ecombinant Human Bone Morphogenetic Protein-2 Reagent Industry Forecast鈥� looks at past sales and reviews total world Recombinant Human Bone Morphogenetic Protein-2 Reagent sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Human Bone Morphogenetic Protein-2 Reagent sales for 2025 through 2031. With Recombinant Human Bone Morphogenetic Protein-2 Reagent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Bone Morphogenetic Protein-2 Reagent industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Bone Morphogenetic Protein-2 Reagent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Bone Morphogenetic Protein-2 Reagent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Recombinant Human Bone Morphogenetic Protein-2 Reagent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Bone Morphogenetic Protein-2 Reagent and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Bone Morphogenetic Protein-2 Reagent.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Bone Morphogenetic Protein-2 Reagent market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
笔耻谤颈迟测锛�95%
Purity 鈮�95%
Segmentation by Application:
University
Research Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
Abbkine
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
ENZO
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Human Bone Morphogenetic Protein-2 Reagent market?
What factors are driving Recombinant Human Bone Morphogenetic Protein-2 Reagent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Bone Morphogenetic Protein-2 Reagent market opportunities vary by end market size?
How does Recombinant Human Bone Morphogenetic Protein-2 Reagent break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Recombinant Human Bone Morphogenetic Protein-2 Reagent by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Recombinant Human Bone Morphogenetic Protein-2 Reagent by Country/Region, 2020, 2024 & 2031
2.2 Recombinant Human Bone Morphogenetic Protein-2 Reagent Segment by Type
2.2.1 笔耻谤颈迟测锛�95%
2.2.2 Purity 鈮�95%
2.3 Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Type
2.3.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales Market Share by Type (2020-2025)
2.3.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue and Market Share by Type (2020-2025)
2.3.3 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Sale Price by Type (2020-2025)
2.4 Recombinant Human Bone Morphogenetic Protein-2 Reagent Segment by Application
2.4.1 University
2.4.2 Research Center
2.5 Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Application
2.5.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Sale Market Share by Application (2020-2025)
2.5.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue and Market Share by Application (2020-2025)
2.5.3 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Breakdown Data by Company
3.1.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Sales by Company (2020-2025)
3.1.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales Market Share by Company (2020-2025)
3.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Revenue by Company (2020-2025)
3.2.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue by Company (2020-2025)
3.2.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue Market Share by Company (2020-2025)
3.3 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Sale Price by Company
3.4 Key Manufacturers Recombinant Human Bone Morphogenetic Protein-2 Reagent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Location Distribution
3.4.2 Players Recombinant Human Bone Morphogenetic Protein-2 Reagent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Recombinant Human Bone Morphogenetic Protein-2 Reagent by Geographic Region
4.1 World Historic Recombinant Human Bone Morphogenetic Protein-2 Reagent Market Size by Geographic Region (2020-2025)
4.1.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Recombinant Human Bone Morphogenetic Protein-2 Reagent Market Size by Country/Region (2020-2025)
4.2.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Sales by Country/Region (2020-2025)
4.2.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales Growth
4.4 APAC Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales Growth
4.5 Europe Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales Growth
4.6 Middle East & Africa Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales Growth
5 Americas
5.1 Americas Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Country
5.1.1 Americas Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Country (2020-2025)
5.1.2 Americas Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue by Country (2020-2025)
5.2 Americas Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Type (2020-2025)
5.3 Americas Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Region
6.1.1 APAC Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Region (2020-2025)
6.1.2 APAC Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue by Region (2020-2025)
6.2 APAC Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Type (2020-2025)
6.3 APAC Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Recombinant Human Bone Morphogenetic Protein-2 Reagent by Country
7.1.1 Europe Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Country (2020-2025)
7.1.2 Europe Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue by Country (2020-2025)
7.2 Europe Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Type (2020-2025)
7.3 Europe Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Human Bone Morphogenetic Protein-2 Reagent by Country
8.1.1 Middle East & Africa Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Country (2020-2025)
8.1.2 Middle East & Africa Recombinant Human Bone Morphogenetic Protein-2 Reagent Revenue by Country (2020-2025)
8.2 Middle East & Africa Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Type (2020-2025)
8.3 Middle East & Africa Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Bone Morphogenetic Protein-2 Reagent
10.3 Manufacturing Process Analysis of Recombinant Human Bone Morphogenetic Protein-2 Reagent
10.4 Industry Chain Structure of Recombinant Human Bone Morphogenetic Protein-2 Reagent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Bone Morphogenetic Protein-2 Reagent Distributors
11.3 Recombinant Human Bone Morphogenetic Protein-2 Reagent Customer
12 World Forecast Review for Recombinant Human Bone Morphogenetic Protein-2 Reagent by Geographic Region
12.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Market Size Forecast by Region
12.1.1 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Forecast by Region (2026-2031)
12.1.2 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Forecast by Type (2026-2031)
12.7 Global Recombinant Human Bone Morphogenetic Protein-2 Reagent Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.2.3 Bio-Techne Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 Scientists Helping Scientists
13.3.1 Scientists Helping Scientists Company Information
13.3.2 Scientists Helping Scientists Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.3.3 Scientists Helping Scientists Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Scientists Helping Scientists Main Business Overview
13.3.5 Scientists Helping Scientists Latest Developments
13.4 Abcam Limited
13.4.1 Abcam Limited Company Information
13.4.2 Abcam Limited Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.4.3 Abcam Limited Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abcam Limited Main Business Overview
13.4.5 Abcam Limited Latest Developments
13.5 FUJIFILM Irvine Scientific
13.5.1 FUJIFILM Irvine Scientific Company Information
13.5.2 FUJIFILM Irvine Scientific Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.5.3 FUJIFILM Irvine Scientific Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 FUJIFILM Irvine Scientific Main Business Overview
13.5.5 FUJIFILM Irvine Scientific Latest Developments
13.6 BD Biosciences
13.6.1 BD Biosciences Company Information
13.6.2 BD Biosciences Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.6.3 BD Biosciences Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 BD Biosciences Main Business Overview
13.6.5 BD Biosciences Latest Developments
13.7 Bio-Rad Laboratories, Inc.
13.7.1 Bio-Rad Laboratories, Inc. Company Information
13.7.2 Bio-Rad Laboratories, Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories, Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bio-Rad Laboratories, Inc. Main Business Overview
13.7.5 Bio-Rad Laboratories, Inc. Latest Developments
13.8 BPS Bioscience, Inc.
13.8.1 BPS Bioscience, Inc. Company Information
13.8.2 BPS Bioscience, Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.8.3 BPS Bioscience, Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 BPS Bioscience, Inc. Main Business Overview
13.8.5 BPS Bioscience, Inc. Latest Developments
13.9 Elabscience
13.9.1 Elabscience Company Information
13.9.2 Elabscience Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.9.3 Elabscience Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Elabscience Main Business Overview
13.9.5 Elabscience Latest Developments
13.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
13.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
13.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Main Business Overview
13.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Latest Developments
13.11 Abbkine
13.11.1 Abbkine Company Information
13.11.2 Abbkine Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.11.3 Abbkine Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Abbkine Main Business Overview
13.11.5 Abbkine Latest Developments
13.12 Beijing Biocreative Technology Co., Ltd.
13.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
13.12.2 Beijing Biocreative Technology Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.12.3 Beijing Biocreative Technology Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Beijing Biocreative Technology Co., Ltd. Main Business Overview
13.12.5 Beijing Biocreative Technology Co., Ltd. Latest Developments
13.13 Shanghai Yaji Biotechnology Co., Ltd.
13.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
13.13.2 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.13.3 Shanghai Yaji Biotechnology Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Shanghai Yaji Biotechnology Co., Ltd. Main Business Overview
13.13.5 Shanghai Yaji Biotechnology Co., Ltd. Latest Developments
13.14 Cellverse Co., Ltd.
13.14.1 Cellverse Co., Ltd. Company Information
13.14.2 Cellverse Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.14.3 Cellverse Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Cellverse Co., Ltd. Main Business Overview
13.14.5 Cellverse Co., Ltd. Latest Developments
13.15 Dalian Meilun Biotech Co., Ltd.
13.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
13.15.2 Dalian Meilun Biotech Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.15.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Dalian Meilun Biotech Co., Ltd. Main Business Overview
13.15.5 Dalian Meilun Biotech Co., Ltd. Latest Developments
13.16 Sino Biological,Inc.
13.16.1 Sino Biological,Inc. Company Information
13.16.2 Sino Biological,Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.16.3 Sino Biological,Inc. Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Sino Biological,Inc. Main Business Overview
13.16.5 Sino Biological,Inc. Latest Developments
13.17 Prospec-Tany Technogene Ltd
13.17.1 Prospec-Tany Technogene Ltd Company Information
13.17.2 Prospec-Tany Technogene Ltd Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.17.3 Prospec-Tany Technogene Ltd Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Prospec-Tany Technogene Ltd Main Business Overview
13.17.5 Prospec-Tany Technogene Ltd Latest Developments
13.18 ENZO
13.18.1 ENZO Company Information
13.18.2 ENZO Recombinant Human Bone Morphogenetic Protein-2 Reagent Product Portfolios and Specifications
13.18.3 ENZO Recombinant Human Bone Morphogenetic Protein-2 Reagent Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 ENZO Main Business Overview
13.18.5 ENZO Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
